Introduction
Stock pitches test whether you can synthesize everything you know about a healthcare company into a concise, analytical investment recommendation. Unlike the deal discussion question (which asks you to analyze someone else's transaction), the stock pitch asks you to generate your own investment thesis. This requires understanding the company's business model, its valuation relative to intrinsic value, the catalysts that will move the stock, and the risks that could invalidate your thesis. In healthcare, each sub-sector demands a different analytical emphasis.
The Universal 5-Part Framework
Every healthcare stock pitch follows the same high-level structure, but the content of each section varies by sub-sector.
| Section | Time | Purpose |
|---|---|---|
| Company overview | 15-20 sec | What the company does, sub-sector, size |
| Investment thesis | 45-60 sec | Why the stock is mispriced (the core argument) |
| Catalysts | 20-30 sec | What will move the stock toward your target |
| Valuation | 20-30 sec | How you derived your target price |
| Risks | 15-20 sec | What could go wrong (and why the risk is manageable) |
- Implied Probability of Success
A reverse-engineering technique used in biotech stock analysis where the analyst calculates what probability of clinical success the market is currently pricing into the stock. If a biotech company has a single Phase 2 asset and the stock trades at $1 billion market cap, but the rNPV at base-case probability of success yields $2 billion, the market is pricing a lower POS than the base case. Conversely, if the rNPV is only $500 million, the market is pricing a higher POS. Identifying the gap between implied POS and your own assessment is the foundation of most biotech stock pitches.
Pharma Stock Pitch Framework
The core investment thesis for a pharma stock almost always revolves around the relationship between the patent cliff and the replacement pipeline. The question is whether the market is correctly pricing the company's ability to replace revenue that will be lost to LOE.
Investment thesis construction: "The market is undervaluing [Company]'s pipeline replacement strategy. The stock is trading at [X]x forward earnings, reflecting the market's concern about [specific product] LOE in [year]. However, the market is not fully crediting [specific pipeline assets or recent acquisitions] that I believe will generate [estimated revenue] by [year], partially offsetting the LOE-driven revenue decline."
Healthcare-specific catalysts: FDA approval decisions, clinical trial readouts, acquisition announcements, IRA negotiation outcomes, biosimilar entry timelines.
Healthcare-specific risks: Clinical trial failure, FTC antitrust challenges to planned acquisitions, generic/biosimilar competition arriving earlier than expected, GTN pressure from PBM negotiation.
Biotech Stock Pitch Framework
The biotech stock pitch centers on implied probability of success. The key analytical skill is calculating what POS the market is pricing and arguing why your estimate differs.
Investment thesis construction: "The market is pricing [Company]'s lead Phase [X] asset at an implied probability of success of [Y]%, based on the current stock price, net cash, and my peak sales estimate. I believe the actual POS is [higher/lower] because [specific clinical data, competitive landscape, or regulatory signal]."
Healthcare-specific catalysts: Phase readout dates (the most binary catalysts in all of healthcare), FDA regulatory milestones (IND acceptance, Breakthrough designation, PDUFA dates), partnership or licensing announcements.
Device Stock Pitch Framework
Device stock pitches focus on procedure volume trends and the company's competitive positioning within its market.
Investment thesis construction: "The market is undervaluing [Company]'s revenue growth trajectory because it is applying an average [multiple] without adjusting for [specific growth driver: new product launch, procedure volume acceleration, market share gain from technology differentiation]."
Healthcare-specific catalysts: New product launches (510(k) or PMA approvals), procedure volume data (quarterly hospital utilization reports), M&A activity (tuck-in acquisitions that expand the product portfolio), clinical data supporting expanded indications.
Healthcare-specific risks: ASP erosion from GPO negotiation, competitive technology disruption, GLP-1 demand displacement for cardiovascular and bariatric devices, reimbursement changes.
Services Stock Pitch Framework
Services pitches evaluate the quality of growth (same-store versus acquisition-driven) and the sustainability of margin expansion.
Investment thesis construction: "The market is mispricing [Company] because it is applying a [multiple] that reflects concern about [specific issue: payer mix shift, reimbursement pressure, integration execution]. However, [Company]'s same-store growth of [X]% and commercial payer mix of [Y]% support a premium valuation relative to peers."
The next article covers how to research a bank's healthcare practice, providing the five-dimension framework for understanding a bank's healthcare group before your interview.
Free Interview PDF Guide